Dietary caffeine: “unnatural” exposure requiring precaution?

References

• Carter, A. J., O’Connor, W. T., Carter, M. J., & Ungerstedt, U. (1995). Caffeine enhances acetylcholine release in the hippocampus in vivo by a selective interaction with adenosine A1 receptors. Journal of Pharmacology and Experimental Therapeutics, 273, 637–642
   PubMed Web of Science ®Google Scholar
• Cauli, O., & Morelli, M. (2005). Caffeine and the dopaminergic system. Behavioural Pharmacology, 16, 63–77
   PubMed Web of Science ®Google Scholar
• Cavin, C., Holzhaeuser, D., Scharf, G., Constable, A., Huber, W. W., & Schilter, B. (2002). Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food & Chemical Toxicology, 40, 1155–1163
   PubMed Web of Science ®Google Scholar
• Centonze, S., Boeing, H., Leoci, C., Guerra, V., & Misciagna, G. (1994). Dietary habits and colorectal cancer in a low-risk area. Results from a population-based case--control study in southern Italy. Nutrition and Cancer, 21, 233–246
   PubMed Web of Science ®Google Scholar
• Chen, J. F., Xu, K., Petzer, J. P., Staal, R., Xu, Y. H., Beilstein, M., Sonsalla, P. K., Castagnoli, K., Castagnoli, N. Jr., & Schwarzschild, M. A. (2001). Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson’s disease. Journal of Neuroscience, 21, RC143--RC149
   PubMed Web of Science ®Google Scholar
• Chvasta, T. E., & Cooke, A. R. (1971). Absorption and emptying of caffeine from the human stomach. Gastroenterology, 61, 838–843
   PubMed Web of Science ®Google Scholar
• Chyou, P. H., Nomura, A. M., & Stemmermann, G. N. (1993). A prospective study of diet, smoking, and lower urinary tract cancer. Annals of Epidemiology, 3, 211–216
   PubMedGoogle Scholar
• Clausson, B., Granath, F., Ekbom, A., Lundgren, S., Nordmark, A., Signorello, L. B., & Cnattingius, S. (2002). Effect of caffeine exposure during pregnancy on birth weight and gestational age. American Journal of Epidemiology, 155, 429–436
   PubMed Web of Science ®Google Scholar
• Dunwiddie, T. V., & Masino, S. A. (2001). The role and regulation of adenosine in the central nervous system. Annual Review of Neuroscience, 24, 31–55
   PubMed Web of Science ®Google Scholar
• FDA Consumer Health Information. FDA to investigate added caffeine. Washington, DC: United States Food and Drug Administration. Avaialble at: http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/UCM350740.pdf [last accessed 10 May 2013]
   Google Scholar
• Griffiths, R. R., & Vernotica, E. M. (2000). Is caffeine a flavoring agent in cola soft drinks? Archives of Family Medicine, 9, 727–734
   PubMedGoogle Scholar
• Heatherley, S. V., Hayward, R. C., Seers, H. E., Rogers, P. J. (2005). Cognitive and psychomotor performance, mood, and pressor effects of caffeine after 4, 6 and 8 h caffeine abstinence. Psychopharmacology, 178, 461–470
   PubMed Web of Science ®Google Scholar
• James, J. E. (1997a). Understanding Caffeine: A Biobehavioral Analysis. Thousand Oaks, CA: Sage Publications
   Google Scholar
• James, J. E. (1997b). Caffeine and blood pressure: Habitual use is a preventable cardiovascular risk factor. Lancet, 349, 279–281
   PubMed Web of Science ®Google Scholar
• James, J. E. (2004). A critical review of dietary caffeine and blood pressure: A relationship that should be taken more seriously. Psychosomatic Medicine, 66, 63–71
   PubMed Web of Science ®Google Scholar
• James, J. E. (2011). Caffeine. In B. Johnson (Ed.), Addiction Medicine: Science and Practice (Vol. 1, pp. 551–583). New York, NY: Springer
   Google Scholar
• James, J. E. (2012a). Caffeine psychopharmacology and effects on cognitive performance and mood. In L. Riby, M. Smith, & J. Foster (Eds.), Nutrition and Cognitive Performance: A Lifespan Perspective (pp. 270–301). London: Palgrave Macmillan
   Google Scholar
• James, J. E. (2012b). Coffee and Mortality: Urgent need for clinical trials to assess putative benefits and harms. Journal of Caffeine Research, 2, 53–54. [Editorial]
   Google Scholar
• James, J. E. (2013). Death by caffeine: How many caffeine-related fatalities and near – misses must there be before we regulate? Journal of Caffeine Research, 2, 149–152
   Google Scholar
• James, J. E., Kristjansson, A. L., & Sigfusdottir, I. D. (2011). Adolescent substance use, sleep, and academic achievement: Evidence of harm due to caffeine. Journal of Adolescence, 34, 665–673
   PubMed Web of Science ®Google Scholar
• James, J. E., & Rogers, P. J. (2005). Effects of caffeine on performance and mood: Withdrawal reversal is the most plausible explanation. Psychopharmacology, 182, 1–8
   PubMed Web of Science ®Google Scholar
• Juliano, L. M., & Griffiths, R. R. (2004). A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology, 176, 1–29
   PubMed Web of Science ®Google Scholar
• Keast, R. S., & Riddell, L. J. (2007). Caffeine as a flavor additive in soft-drinks. Appetite, 49, 255–259
   PubMed Web of Science ®Google Scholar
• Lane, J. D. (2011). Caffeine, glucose metabolism, and type 2 diabetes. Journal of Caffeine Research, 1, 23–28
   Google Scholar
• National Sleep Foundation. (2006). 2006 Sleep in America Poll: Summary of Findings. Washington, DC: National Sleep Foundation
   Google Scholar
• Reissig, C. J., Strain, E. C., & Griffiths, R. R. (2009). Caffeinated energy drinks: a growing problem. Drug and Alcohol Dependence, 99, 1–10
   PubMed Web of Science ®Google Scholar
• Rodriguez del Rey, Z., Granek, E. F., & Sylvester, S. (2012). Occurrence and concentration of caffeine in Oregon coastal waters. Marine Pollution Bulletin, 64, 1417–1424
   PubMed Web of Science ®Google Scholar
• Rose, G. (1981). Strategy of prevention: Lessons from cardiovascular disease. British Medical Journal, 282, 847–851
   PubMed Web of Science ®Google Scholar
• Tosun, J. (2013). Risk Regulation in Europe: Assessing the Application of the Precautionary Principle (pp. 39–49). London: Springer
   Google Scholar